Patient Satisfaction and Clinical Experience With the Tandem t:slim X2 With Control-IQ Technology Advanced Hybrid...

Area of Science:

• Endocrinology
• Diabetes Management
• Medical Devices

Background:

• Automated insulin delivery (AID) systems are transforming diabetes care.
• The t:slim X2 with Control-IQ Technology represents an advancement in AID systems.

Purpose of the Study:

• To evaluate patient satisfaction with the t:slim X2 AID system.
• To assess the clinical effectiveness of Control-IQ Technology in managing A1C levels.

Main Methods:

• Retrospective electronic health record review of 99 patients using the Control-IQ system.
• Glucose Monitoring Satisfaction Survey (GMSS) administered to assess patient satisfaction.
• Analysis of A1C changes from baseline at 3, 6, and 12 months.

Main Results:

• Patients reported high overall satisfaction with a mean GMSS score of 4.0 ± 0.6.
• A1C levels decreased significantly from baseline: 0.6% at 3 months, 0.7% at 6 months, and 0.8% at 12 months.
• No significant difference in satisfaction was observed between patients with A1C ≤7% and those with higher levels.

Conclusions:

• The t:slim X2 with Control-IQ Technology is associated with high patient satisfaction.
• The system effectively reduces A1C levels in adults with diabetes.
• Continued use of AID systems like Control-IQ shows sustained clinical benefits.